In a new study, researchers in Switzerland have now developed an innovative method for straightforward injection into the nucleus of a living cell, taking advantage of the nanoscale accuracy and small probe size of AFM and the possibility to handle fluid under pressure-control through the integrated microchannel.
"Invented in 1904 and optimized in the 1970s, microinjection using glass pipettes represents the most widely used approach for intracellular injection," Julia A. Vorholt, a professor at the Institute of Microbiology at ETH Zurich, explains to Nanowerk. "However, microinjection has major limitations, such as the manual dexterity required to handle glass micropipettes, the relatively high risk to damage the cells, the difficulties to deliver small (femtoliter) volumes, and the lack of readout to monitor the penetration of the pipette through the cell membrane(s)."
To overcome these limitations, Vorholt and her group, working with scientists from ETH's Laboratory of Biosensors and Bioelectronics, developed a protocol that makes the intranuclear injection a precise and reliable procedure.
A) Schematic representation of the intranuclear injection using fluidic force microscopy. The setup features an inverted microscope, an AFM, and a microfluidic probe connected to a pressure controller. Optical-, force- and pressure-monitoring are performed simultaneously along the entire intranuclear injection process. B) Scanning electron micrographs of a FluidFM injection probe; a triangular aperture was milled by focused ion beam at the front facet of the pyramidal tip. (Reprinted with permission from Wiley-VCH Verlag)
In addition, continuous force-monitoring enabled the detection in situ of the probe penetration through the cytoplasmic and nuclear membranes. Once the probe inserted in the intranuclear compartment, a defined pressure pulse was applied to release the biomolecule solution.
"By finely tuning the pressure pulses, we could inject volumes ranging from one or two picoliters down to a few tens of femtoliters" says Guillaume-Gentil.
The team demonstrated the high potential of this approach in single-cell transfection experiments in which single-cell expression of green fluorescent protein (GFP) was induced by the intranuclear injection of plasmid DNA encoding the fluorescent protein.
"Our approach uniquely enabled reliable probe insertion with a simultaneous readout of the membrane perforation events, maximal injection efficiency (100%), minimal damage to the cell – cells survived injection, expressed proteins encoded in an injected plasmid, and divided as in standard culture conditions – and control over the volumes injected," Vorholt summarizes the team's results.
Transfection of a HeLa cell with pmaxGFP; the phase contrast images show the cell before (A) and during (B) injection. The fluorescence images show the cell immediately (C) and 2 days (D) after injection. DexTRITC (red) co-injected with the plasmid remained localized in the nucleus, and 2 days post-injection the cell was producing GFP (green). The arrow in A) indicates the targeted cell. (Reprinted with permission from Wiley-VCH Verlag)
The potential applications for straightforward and standardized injection into cell nuclei with FluidFM are wide-ranging. Vorholt points out that the possibility to release defined quantities of DNA, RNA, or proteins directly into single cell nucleus allows for gaining new insights into critical intracellular processes at the single-cell level. "The technology will enable examining the role of specific genes or proteins, offering great opportunities in various field of cell biology research such as neuroscience, cancer research, or stem cell studies,".